BioCardia, Inc.BCDANASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -100.00% | -100.00% | -100.00% | -100.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +96.18% | +82.69% | +63.72% | +169.57% | +122.07% |
| Weighted Average Shares Diluted Growth | +96.18% | +82.69% | +63.72% | +169.57% | +122.07% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -90.38% | -100.00% | -100.00% | +0.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +67.25% | +24.67% | -19.15% | -27.72% | -1.90% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | -57.03% |
| Debt Growth | -25.25% | -27.68% | -30.78% | -34.53% | -38.95% |
| R&D Expense Growth | -50.27% | +22.40% | +23.29% | +71.00% | +0.11% |
| SG&A Expenses Growth | +0.00% | +0.00% | +0.00% | +0.00% | -37.38% |